THURSDAY, October 15, 2009 Poster Area
Poster Session P-1/1: PHARMACOLOGY OF NERVOUS SYSTEM
Poster Commission Members: President: Spano P. F. (Brescia) Members: Brunello N. (Milan), Bruno V. (Rome), Di Luca M. (Milan), Pellegrini-Giampietro D. (Florence), Serra M. (Cagliari), Sortino M.A. (Catania)
(5 awards)

 

OSTEOPENIA BY RISPERIDONE-INDUCED HYPERPROLACTINEMIA: A CASE REPORT
Capasso A., Milano W., Milano L., Siano C., Petrella C. (Fisciano SA)
THE GHB ANALOGUE N-(4-TRIFLUOROMETHYL)-4-METHOXYBUTANAMIDE PREVENTS THE BEHAVIORAL AND NEURODEGENERATIVE CONSEQUENCES OF REPEATED EPISODES OF ALCOHOL WITHDRAWAL, IN RATS.
Tacchi R., Spaccapelo L., Maccio L., Ferrari A., Rivasi F., Bertolini A. (Modena)
LIGHT AND SHADE OF THERAPEUTIC DRUG MONITORINGOF ANTIEPILPTIC DRUGS.
Furlanut M., Cojutti P., Franceschi L. (Udine)
SEROTONIN2C RECEPTORS IN THE MEDIAL PREFRONTAL CORTEX FACILITATE COCAINE-INDUCED DOPAMINE RELEASE IN THE RAT NUCLEUS ACCUMBENS
Leggio G., Cathala A., Moison D., Cunningham K., Piazza P., Spampinato U. (Bordeaux, Catania, Galveston)
ASSOCIATION STUDY BETWEEN MEDICATION OVERUSE HEADACHE AND POLYMORPHIC VARIANTS OF SEROTONERGIC GENES.
Terrazzino S., Sances G., Cereda C., Viana M., Nappi G., Rinaldi M., Canonico P., Genazzani A. (Novara, Pavia)
OPPOSITE REGULATION OF CB1-MEDIATED EFFECTS BY PRE- AND POST-SYNAPTIC ADENOSINE A2A RECEPTORS IN THE STRIATUM
Tebano M., Martire A., Kofalvi A., Chiodi V., Domenici M., Pepponi R., Ferreira S., Ferrante A., Chen J., Cunha R., Popoli P. (Roma, Boston, Coimbra)
DEATH RESISTANT NEURAL STEM CELL REGENERATE NEURONAL TISSUE AND PROMOTE FUNCTIONAL RECOVERY AFTER TRANSPLANTATION IN A SPINAL CORD INJURY MODEL
Marfia G., Madaschi L., Merli D., Menarini M., Marra F., Gualeni A., Naselli F., Carelli S., Di Giulio A., Gorio A. (Milano, Rozzano MI, Imola BO)
DEATH RESISTANT NEURAL PROGENITORS YIELD MOSTLY NEURONS: AN ERYTHROPOIETIN-DEPENDENT PROCESS
Marra F., Marfia G., Madaschi L., Merli D., Bottai D., Carelli S., Menarini M., Di Giulio A., Gorio A. (Milano, Imola BO, Rozzano MI)
ERYRHROPOIETIN INCREASE NEURONAL DIFFERENTIATION OF NEURAL STEM CELLS AND DEATH RESISTANT NEURAL STEM CELLS
Gualeni A., Naselli F., Merli D., Menarini M., Marra F., Gervasi N., Carelli S., Madaschi L., Marfia G., Di Giulio A., Gorio A. (Milano, Imola BO, Rozzano MI)
FAILURE OF THE CB1 RECEPTOR ANTAGONIST SR141716A (RIMONABANT) TO INDUCE ANTIDEPRESSANT-LIKE EFFECT IN THE RAT FORCED SWIMMING TEST
Bogliolo V., Garzia A., Serra G., D'Aquila P., Serra G. (Sassari, Roma)
MAGNETIC AND FLUORESCENCE LABELLING FOR IN VIVO NEURAL STEM CELL TRANSPLANTATION MONITORING
Merli D., Lui R., Marfia G., Clerici M., Ottobrini L., Lucignani G., Carelli S., Marra F., Di Giulio A., Gorio A. (Milano, Rozzano MI)
PALMITOYLTHENOLAMIDE CONTROLS THE PRO-ANGIOGENIC PATHWAY INDUCED BY BETA AMYLOID IN GLIAL CELLS
Cipriano M., Scuderi C., De Filippis D., Esposito G., Di Marzo V., Steardo L., Iuvone T. (Napoli, Roma)
HMGB1-EVOKES GLUTAMATE RELEASE FROM GLIOSOMES FRESHLY PREPARED FROM ADULT MOUSE BRAIN.
MILANESE M., BONIFACINO T., ZAPPETTINI S., PEDRAZZI M., PASSALACQUA M., SPARATORE B., MELLONI E., BONANNO G. (Genova)
ABSENCE OF ENDOGENOUS INTERLEUKIN-10 ENHANCES SECONDARY INFLAMMATORY PROCESS AFTER SPINAL CORD COMPRESSION INJURY IN MICE
Genovese T., Esposito E., Mazzon E., Di Paola R., Caminiti R., Bramanti P., Cappelani A., Cuzzocrea S. (Messina, Napoli, Catania)
INTRAVENOUS MESENCHYMAL STEM CELLS ADMINISTRATION INDUCES SURVIVAL AND SYMPTOM AMELIORATION IN MUTANT SOD1 G93A MICE.
BONIFACINO T., ZAPPETTINI S., MILANESE M., CASAZZA S., CAPONNETTO C., UCCELLI A., BONANNO G. (Genova)
FAILURE OF ATYPICAL ANTIPSYCHOTICS TO INDUCE ANHEDONIA: BEHAVIOURAL EVIDENCE FOR THE ROLE OF 5-HT2 RECEPTORS.
D'Aquila P., Cabras M., Modde C., Rassu C., Serra G., Ravizza R., Molteni R., Monti E., Gariboldi M., Vellecco V., Mattace Raso G., Brancaleone V., Roviezzo F., Bucci M., Cirino G., Paterniti I., Esposito E., Genovese T., Mazzon E., Galuppo M., Bramanti P., Cuzzocrea S. (Sassari)
NEUROPROTECTIVE EFFECT OF DEYDROEPIANDROSTERONE IN HEPATIC ENCEPHALOPATHY :POSSIBLE INVOLVEMENT OF PROTEIN KINASE C, EPSILON ISOFORM.
Geminiani E., Corsi L., Carnevale G., Zanoli P., Baraldi M. (Modena)
BB 16 AS NEW COMPOUND FOR MEMORY RELATED DISORDERS
Di Viesti V., Carnevale G., Zavatti M., Zanoli P., Cannazza G., Braghiroli D., Baraldi M. (Modena)
PHENOTYPICAL CHARACTERIZATION OF THIRD TRIMESTER HUMAN AMNIOTIC FLUID CELLS: A NEW RESERVOIR OF STEM CELLS?
Bottai D., Cigognini D., Nicora E., Ripamonti E., Adami R., Abrignani S., Moro M., Rebulla P., Menarini M., Di Giulio A., Gorio A. (Milano, Imola BO)
THIRD TRIMESTER HUMAN AMNIOTIC FLUID CELLS WITH POTENTIAL FOR THERAPY IN NEURODEGENERATIVE DISORDERS
Cigognini D., Nicora E., Ripamonti E., Adami R., Menarini M., Di Giulio A., Bottai D., Gorio A. (Milano, Imola BO)
ROLE OF MATRIX METALLOPROTEINASES IN RETINAL GANGLION CELLS (RGCS) LOSS INDUCED BY RETINAL ISCHEMIA/REPERFUSION.
Russo R., Cavaliere F., Varano G., Rombola' L., Corasaniti M., Bagetta G., Morrone L. (Cosenza, Catanzaro)
MELANOCORTINS PROTECT AGAINST CENTRAL AND PERIPHERAL DAMAGE FOLLOWING CEREBRAL ISCHEMIA THROUGH A VAGUS NERVE-MEDIATED MECHANISM
Giuliani D., Ottani A., Galantucci M., Minutoli L., Bitto A., Di Stefano V., Altavilla D., Squadrito F., Guarini S. (Modena, Messina)
ROLE OF ENDOCANNABINOID SYSTEM AND VANILLOID TRPV1 CHANNELS IN THE PHENOTYPE OF DOPAMINE D3 RECEPTOR KNOCK-OUT "D3(-/-)" MICE
Micale V., Cristino L., Tamburella A., Petrosino S., Leggio G., Di Marzo V., Drago F. (Catania, Pozzuoli NA)
I NOOTROPI: "SMART DRUGS" ?
Runci F., Fiaschi A., Barberi L., Passarello F., Montefrancesco G., Giorgi G. (Siena)
MOLECULES ACTING ON CB1 RECEPTOR AND THEIR EFFECTS ON MORPHINE WITHDRAWAL IN VITRO
Festa M., Capasso A. (Salerno)
COMPARISON OF THE ANTIEPILEPTOGENIC EFFECTS OF AN EARLY LONG-TERM TREATMENT WITH ETHOSUXIMIDE OR LEVETIRACETAM IN A GENETIC ANIMAL MODEL OF ABSENCE EPILEPSY.
Russo E., Citraro R., Scicchitano F., Marra R., Donato Di Paola E., De Fazio S., De Sarro G. (Catanzaro)
NEUROCHEMICAL AND BEHAVIORAL EFFECTS OF CARVACROL
Zotti M., Avato P., Trabace L. (Foggia, Bari)
A-LACTOALBUMIN, A WHEY PROTEIN RICH IN TRYPTOPHAN, SHOWS EFFICACY IN RODENT MODELS OF EPILEPSY.
Citraro R., Russo E., Scicchitano F., De Fazio S., Marra R., Mainardi P., Perucca E., De Sarro G. (Catanzaro, Genova, Pavia)
LONG TERM ANTIEPILEPTIC DRUGS TREATMENT, ABSENCE EPILEPSY AND DEPRESSION: A CORRELATION STUDY.
De Fazio S., Russo E., Citraro R., Scicchitano F., De Fazio P., Segura Garcia C., Gareri P., De Sarro G., Raiteri L., Luccini E., Romei C. (Catanzaro)
EFFECTS OF FLAVONOIDS GENISTEIN AGLYCONE AND FLAVOCOXID IN THE EXPERIMENTAL MOUSE MODEL OF DUCHENNE MUSCULAR DYSTROPHY.
Bitto A., Polito F., Irrera N., Messina S., Altavilla D., Guarini S., Caputi A., Squadrito F. (Messina, Modena)
MELATONIN REGULATES MATRIX METALLOPROTEINASE -2 AND -9, AND REDUCES STRESS-ACTIVATED/MITOGEN-ACTIVATED PROTEIN KINASES IN SPINAL CORD INJURY
Esposito E., Genovese T., Caminiti R., Bramanti P., Meli R., Cuzzocrea S. (Massina, Napoli)
PRESYNAPTIC NICOTINIC AND D2 RECEPTORS FUNCTIONALLY INTERACT ON DOPAMINERGIC NERVE ENDINGS OF RAT AND MOUSE NUCLEUS ACCUMBENS
Zappettini S., Grilli M., Lagomarsino F., Zoli M., Marchi M. (Genova, Modena)
MK801, A N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTAGONIST, REDUCES SIGNALING PATHWAYS INVOLVED IN AN EXPERIMENTAL MODEL OF SPINAL CORD TRAUMA.
Paterniti I., Esposito E., Genovese T., Mazzon E., Galuppo M., Bramanti P., Cuzzocrea S. (Messina)
GSK3β INHIBITION PROTECTS MOUSE CORTICAL NEURONS AGAINST OXYGEN-GLUCOSE DEPRIVATION INJURY
delbarba a., bertolotti p., dossena m., nisoli e., valerio a. (Milano, Brescia)
HEPATIC MITOCHONDRIA OBTAINED FROM 6-OHDA-LESIONED PARKINSONIAN RATS EXHIBIT DECREASED ENERGY CAPACITY AND MEMBRANE POTENTIAL
Ferrigno A., Armentero M., Rizzo V., Ambrosi G., Richelmi P., Blandini F., Vairetti M. (Pavia)
POSSIBLE ROLE OF TUNNELING NANOTUBES IN NEURODEGENERATIVE DISEASES: INTERCELLULAR TRANSFER OF MITOCHONDRIA, APP AND α-SYNUCLEIN.
Carone C., Genedani S., Agnati L., Filaferro M., Pederzoli F., Leo G. (Modena)
β-AMYLOID FIBRILLATION AND/OR HYPERHOMOCYSTEINEMIA MODIFY STRIATAL PATTERNS OF GLYCOSAMINOGLYCANS: POSSIBLE ROLE IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE.
Pederzoli F., Genedani S., Volpi N., Agnati L., Leo G., Buzzega D., Maccari F., Carone C., Andreoli N., Filaferro M. (Modena)
CHF5074 REDUCES BRAIN β-AMYLOID BURDEN IN A MOUSE MODEL OF ALZHEIMER’S DISEASE BY MODULATING APP AND PS1 INTERACTION
Lanzillotta A., Sarnico I., Hutter-Paier B., Imbimbo B., Windisch M., Pizzi M. (Brescia, Parma, Graz)
STEERED MOLECULAR DYNAMICS SIMULATIONS TO INVESTIGATE THE DUAL PHARMACOLOGY OF THE NOVEL NUCLEOTIDES/LEUKOTRIENES RESPONDING RECEPTOR GPR17
Parravicini C., Ranghino G., Fantucci P., Abbracchio M. (Milano, Bresso MI)
SEIZURE SUSCEPTIBILITY OF HIV-1 TAT-TRANSGENIC MICE: IMPLICATIONS FOR THE ROLE OF TAT IN HIV-1 ASSOCIATED NEUROPATHY (HAN).
Zucchini S., Caputo A., Altavilla G., Brocca Cofano E., Pittaluga A., Corallini A., Simonato M. (Ferrara, Padova, Bethesda, Genova)
ADENOSINE A2A RECEPTORS MODULATE ACTIVATION OF P38 MITOGEN ACTIVATED PROTEIN KINASE IN MURINE BV-2 CELLS
Corti F., Cipriani S., Saura J., Lluis C., Serratosa J., Franco R., Pedata F. (Firenze, Barcelona)
OXIDATIVE STRESS AND EFFECTS OF ANTIOXIDANT TREATMENT IN DISUSED SKELETAL MUSCLES OF HINDLIMB-UNLOADED MICE
Digennaro C., Pierno S., Liantonio A., Giannuzzi V., Camerino G., Dinardo M., Brocca L., Pellegrino M., Bottinelli R., Desaphy J., Conte Camerino D. (Bari, Pavia)
DISUSE-INDUCED SLOW-TWITCH MUSCLE IMPAIRMENT IS AMELIORATED BY IGF-1 OVEREXPRESSION IN HINDLIMB-UNLOADED TRANSGENIC MICE
Pierno S., Liantonio A., Desaphy J., Digennaro C., Giannuzzi V., Gramegna G., Dobrowolny G., Magnani E., Rizzuto E., Musarò A., Conte Camerino D. (Bari, Roma)
PHARMACOLOGICAL MODULATION OF THE ENZYMATIC PATHWAYS INVOLVED IN H2O2 ELEVATION LEADS TO NEUROPROTECTION IN EXPERIMENTAL ISCHEMIA
Armogida M., Amantea D., Cucchiaroni M., Piccirilli S., Guatteo E., Bagetta G., Mercuri N., Nistico R. (Roma, Rende CS)
THE P2Y-LIKE GPR17 RECEPTOR PARTICIPATES IN OLIGODENDROCYTE POSTNATAL MATURATION AND REACTION TO ACUTE AND CHRONIC BRAIN INJURY
Boda E., Mantovan T., Rosa P., Tempia F., Abbracchio M., Buffo A. (Torino, Milano)
THE CB1 AGONIST WIN55,212-2 REDUCES STRIATAL PKA HYPERACTIVITY AND TRPV1 RECEPTOR SENSITIVITY IN DYSKINETIC RATS.
Macheda T., Martinez A., Morgese M., Cassano T., Cuomo V., Giuffrida A. (San Antonio, Foggia, Roma)
MULTI-TARGET-DIRECTED LIGANDS: NEW HISTAMINE H3 RECEPTOR ANTAGONISTS WITH ANTICHOLINESTERASE ACTIVITY
Flammini L., Bertoni S., Saccani F., Incerti M., Morini G., Ballabeni V., Barocelli E. (Parma)
TEMPORAL ANALYSIS OF 17B-ESTRADIOL NEUROPROTECTIVE ACTIVITY AGAINST B-AMYLOID-INDUCED CELL DEATH IN ORGANOTYPIC HIPPOCAMPAL CULTURES.
Merlo S., Spampinato S., Canonico P., Sortino M. (Catania, Novara)
APP OVEREXPRESSION AND ITS GRB2-MEDIATED SIGNALLING MODULATES MAPK ACTIVATION
Nizzari M., Musso A., Pastorino M., Russo C., Florio T. (Genova, Campobasso)
PHARMACOLOGICAL ACTIVATION OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 1 DAMPENS SPIKE AND WAVE DISCHARGES IN THE WAG/RIJ RAT MODEL OF ABSENCE EPILEPSY
Santolini I., Simonyi A., Molinaro G., Mairesse J., Battaglia G., Bruno V., van Luijtelaar G., Ngomba R., Nicoletti F. (Roma, Columbia, Pozzilli IS, Donders)
A NOVEL PHARMACOLOGICAL ACTIVITY FOR THE ALPHA2-DELTA LIGANDS PREGABALIN AND GABAPENTIN: IN VITRO MODULATION OF ADULT NEUROGENESIS.
Valente M., Meneghini V., Francese M., Carraro L., Canonico P., Grilli M. (Novara)
BIOTELEMETRIC MONITORING OF STRIATAL NEUROCHEMISTRY AND BEHAVIOUR IN MPTP-INDUCED RAT MODEL OF PARKINSON’S DISEASE
Puggioni G., Bazzu G., Spissu Y., Rocchitta G., Calia G., Migheli R., Serra P. (Sassari)
A NOVEL ROLE FOR THE RAGE-NF-KAPPAB AXIS IN ADULT SVZ NEUROGENESIS
Meneghini V., Francese M., Carraro L., Valente M., Grilli M. (Novara)
PROTECTIVE EFFECT OF TAT-PARKIN ON NEURONAL CELLS
Grigoletto J., Zusso M., Debetto P., Negro A. (Padova)
EFFECT OF REPEATED MPTP ADMINISTRATION ON STRIATAL ENERGY METABOLISM IN FREELY MOVING RATS
Calia G., Migheli R., Rocchitta G., Puggioni G., Spissu Y., Serra P. (Sassari)
CYCLO OXYGENASE ACTIVITY IN IMMORTALIZED HYPOTHALAMIC NEURONS GT1-7
Mores N., Petrucci G., Errico S., Shohreh R. (Roma, Chieti)
DOMINANT ROLE OF INWARD RECTIFIERK+ CHANNELS IN THE REGULATION OF CARBACHOL-INDUCED EPILEPTIFORM ACTIVITY IN RAT ENTORHINAL CORTEX.
Cataldi M., Avoli M. (Napoli, Montreal, Roma)
EXPOSURE TO RESTRAINT STRESS INCREASES NOP RECEPTOR GENE EXPRESSION IN THE CENTRAL AMYGDALA AND INCREASES THE ANXIOLYTIC-LIKE ACTION OF NOCICEPTIN.
Ubaldi M., De Guglielmo G., Ruggeri B., Soverchia L., Kallupi L., Barbaro G., Massi M., Ciccocioppo R. (Camerino MC)
SURFACE-DECORATED NANOPARTICLES AS DRUG DELIVERY AGENTS TO THE BRAIN
Badiali L., Vergoni A., Tosi G., Ruozi B., Costantino L., Bertolini A., Vandelli M., Forni F. (Modena)
IN VITRO AND IN VIVO PHARMACOLOGICAL CHARACTERIZATION OF THE NEUROPEPTIDE S RECEPTOR ANTAGONIST SHA 68.
Ruzza C., Camarda V., Rizzi A., Trapella C., Pelà M., Guerrini R., Regoli D., Salvadori S., Calò G. (Ferrara)
NEUROPEPTIDE S EVOKES ANXIOLYTIC-LIKE EFFECTS IN RATS VIA NPSR SELECTIVE ACTIVATION
Ruggieri V., Filaferro M., Romano M., Guerrini R., Trapella C., Salvadori S., Rizzi A., Calò G., Viale G. (Modena, Ferrara)
NEUROPROTECTIVE EFFECTS OF ß-AMYLOID MONOMERS
Giuffrida M., Caraci F., Pignataro B., Cataldo S., De Bona P., Bruno V., Molinaro G., Pappalardo G., Messina A., Palmigiano A., Garozzo D., Nicoletti F., Rizzarelli E., Copani A. (Catania, Palermo, Roma, Pozzilli IS)
IN VITRO PHARMACOLOGICAL CHARACTERIZATION OF GF-4, A NOVEL NON-PEPTIDE ANTAGONIST FOR THE NOCICEPTIN/ORPHANIN FQ RECEPTOR
Molinari S., Trapella C., Fischetti C., Camarda V., Guerrini R., Salvadori S., Regoli D., Calò G. (Ferrara)
CONJUGATED LINOLEIC ACID ISOMERS INDUCE ABC HALF-TRANSPORTER RELATIVE GENE EXPRESSION AND MODIFY PROTEIN PROFILE IN X- LINKED ADRENOLEUKODYSTROPHY
Cappiello L., Iannone A., Banni S., Blasevich M., Della Casa L., Rossi E., Giordano E., Cordeddu L., Petroni A. (Milano, Modena, Cagliari)
INHIBITION OF ENDOGENOUS DIPEPTIDYL PEPTIDASE-4 IN ALZHEIMER’S PRONE MICE
Di filippo C., Marfella R., Ferraraccio F., Paolisso G., Rossi F., D'Amico M. (Napoli)
THE PARAVENTRICULAR NUCLEUS OF THE HYPOTHALAMUS IS A NEUROANATOMICAL SUBSTRATE FOR THE INHIBITION OF PALATABLE FOOD INTAKE BY NEUROPEPTIDE S
Cannella N., Cifani C., Fedeli A., Braconi S., Economidou D., Kallupi M., Massi M., Ciccocioppo R. (Camerino MC)
CONGENIC DA.WOKW FEMALES COULD BE SUITABLE MODELS TO ELUCIDATE THE GENETICS OF BINGE EATING?
Micioni Di Bonaventura M., Cifani C., Wilke B., Massi M., Polidori C., Kloting I. (Camerino MC, Karlsburg)
SP PROTECTS CEREBELLAR GRANULE CELLS AGAINST B-AMYLOID-INDUCED APOPTOSIS BY DOWN-REGULATION AND REDUCED ACTIVITY OF KV4 POTASSIUM CHANNELS
Marolda R., Pieri M., Amadoro G., Carunchio I., Ciotti M., Possenti R., Zona C., Petrella C., Severini C. (Roma)
STUDY OF BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) CONTENT CHANGE IN AN EXPERIMENTAL MODEL OF CHRONIC RENAL FAILURE.
Stiaccini G., Mannari C., Guidi A., Silvano E., Migliori M., Scalori V., Giovannini L. (Pisa, L'Aquila, Lido di Camaiore LU)
NF-KB P50 REGULATES ADULT NEUROGENESIS IN THE HIPPOCAMPUS BUT NOT IN THE OLFACTORY BULB
Bortolotto V., Dellarole A., Francese M., Denis-Donini S., Grilli M. (Novara, Milano)
AGE-RELATED MODIFICATIONS OF DISTRIBUTION, SIGNALLING AND FUNCTION OF A1 ADENOSINE RECEPTORS IN THE BRAIN OF A RAT MODEL OF ABSENCE EPILEPSY
TORELLI E., D'ALIMONTE I., CITRARO R., RUSSO E., NARGI E., BUCCELLA S., DI IORIO P., GIULIANI P., ROMANO S., BALLERINI P., CACIAGLI F., DE SARRO G., CICCARELLI R. (Chieti, Catanzaro)
METABOLOMICS OF ENERGY-LINKED ENZYMES IN LYMPHOCYTES FROM ACUTE STROKE PATIENTS
Villa R., Devecchi E., Brera F., Pero G., Gorini A. (Pavia, Lodi, Milano)
PHARMACOLOGICAL MANIPULATION OF DOPAMINERGIC RECEPTORS AND MGLU5 METABOTROPIC GLUTAMATE RECEPTORS INCREASES THE NUMBER OF INTRASTRIATAL TYROSINE HYDROXYLASE-POSITIVE CELLS IN NEONATAL MOUSE STRIATUM
Fardone E., Bucci D., Busceti C., Biagioni F., Trabucco A., Mastroiacovo F., Riozzi B., Gradini R., Battaglia G., Bruno V., Fornai F., Nicoletti F. (Pozzilli IS, Roma, Pisa)
MGLU4 METABOTROPIC GLUTAMATE RECEPTOR-LIKE IMMUNOREACTIVITY IN THE CEREBROSPINAL FLUID OF PATIENTS WITH MULTIPLE SCLEROSIS AND MICE WITH EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
Notartomaso S., D'Amore V., Maione T., Fazio F., Scarselli P., Di Costanzo A., Bellantonio P., Battaglia G., Storto M., Bruno V., Gradini R., Ferraguti F., Nicoletti F., Di Marco R. (Pozzilli IS, Campobasso, Roma, Innsbruck)
PHARMACOLOGICAL ACTIVATION OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 4 IS PROTECTIVE AGAINST FOCAL TRANSIENT ISCHEMIA
Bernabucci M., Mastroiacovo F., Moyanova S., Kortesca L., Mitreva R., Ngomba R., Battaglia G., Bruno V., Nicoletti F. (Pozzilli IS, Roma, Sofia)
THE THALAMIC EXPRESSION OF CANNABINOID RECEPTORS IS REDUCED IN A RAT MODEL OF ABSENCE EPILEPSY
Cianci S., Ngomba R., Gaetani S., van Rijn C., van Luijtelaar G., Colangeli R., Santolini I., Cuomo V., Nicoletti F. (Roma, Nijmegen, Pozzilli IS, Bari)
AMITRIPTYLINE ANTIDEPRESSANT ACTIVITY IS MEDIATED BY ARTEMIN, A GLIAL NEUROTROPHIC-DERIVED FACTOR.
GHELARDINI C., VIVOLI E., SALVICCHI A., DI CESARE MANNELLI L., SCHIAVONE N., BARTOLINI A. (Firenze)
SOCIAL MEMORY IMPAIRMENT IN A TRIPLE-TRANSGENIC MOUSE MODEL OF ALZHEIMER’S DISEASE IS ACCOMPAINED BY MONOAMINERGIC ALTERATIONS
Romano A., Cassano T., Gaetani S., Laconca L., Macheda T., Righetti L., Cianci S., Morgese M., Mastrantonio T., Oddo S., Laferla F., Cuomo V. (Roma, Foggia, San Antonio, Irvine, Bari)
IDENTIFICATION AND IN VITRO CHARACTERIZATION OF THE NOVEL NEUROPEPTIDE S RECEPTOR ANTAGONIST [TBU-D-GLY5]NPS
camarda v., guerrini r., marzola e., trapella c., rizzi a., ruzza c., fiorini s., reinscheid r., regoli d., salvadori s., calo' g. (Ferrara, Irvine)
TRIMETHYLETHIAZOLINE-INDUCED ANXIETY AS A MODEL FOR THE STUDY OF THE MOLECULAR TARGETS OF PREGABALIN IN MICE
Marchiafava M., Matrisciano F., Scaccianoce S., Busceti C., Biagioni F., Nasca C., Orlando R., Melchiorri D., Nicoletti F. (Roma, Pozzilli IS, Catania)
PRECONDITIONING BY NMDA AND DHPG INDUCE TOLERANCE WITH DIFFERENTIAL MECHANISMSIN RAT ORGANOTYPIC HIPPOCAMPAL SLICES EXPOSED TO EXCITOTOXICITY.
Scartabelli T., Gerace E., Zianni E., Landucci E., Gardoni F., Berlinguer Palmini R., Mannaioni G., Moroni F., Di Luca M., Pellegrini-Giampietro D. (Firenze, Milano)
MICROARRAY ANALYSIS IN HIPPOCAMPUS OF RATS TREATED WITH ESCITALOPRAM IN THE CHRONIC ESCAPE DEFICIT MODEL OF DEPRESSION
Caggia F., Alboni S., Valensisi C., Benatti C., Corsini D., Ferrari F., Tagliafico E., Mendlewicz J., Tascedda F., Brunello N. (Modena, Brussels)
ROLE OF THE ENDOCANNABINOID SYSTEM IN A RAT ORGANOTYPIC HIPPOCAMPAL SLICE MODEL OF CEREBRAL ISCHEMIA
Landucci E., Scartabelli T., Gerace E., Boscia F., Moroni F., Pellegrini-Giampietro D. (Firenze, Napoli)
GUANOSINE INDUCES NEURONAL DIFFERENTIATION IN THE HUMAN NEUROBLASTOMA SH-SY5Y CELL LINE
Zanette C., Dell'Ovo V., Traversa U., Florio C. (Trieste)
GPR35 EXPRESSION AND MODULATION OF CAMP PRODUCTION AND INTRACELLULAR CA2+ CONCENTRATION IN CULTURED ASTROCYTES.
Masi A., Cavone L., Sili M., Cozzi A., Berlinguer Palmini R., Cosi C., Mannaioni G., Moroni F. (Firenze)
ACTIVATION OF TRPV4 CHANNELS REDUCE MIGRATION OF GN11 CELLS, A NEUROENDOCRINE MODEL FOR MIGRATION
Fornarelli A., Zaninetti R., Tacchi S., Mesenzani O., Ciarletta M., Distasi C., Cariboni A., Canonico P., Caldarelli A., Genazzani A. (Novara, Milano)
PPARγ MEDIATES CANNABIDIOL ANTIINFLAMMATORY AND NEUROPROTECTIVE EFFECTS IN AN IN VITRO MODEL OF ALZHEIMER’S DISEASE
SCUDERI C., BLASIO A., VALENZA M., STEARDO A., DE FILIPPIS D., IUVONE T., ESPOSITO G., STEARDO L. (Roma, Napoli)
LEPTOMENINGEAL STEM/PROGENITOR CELLS (LESC) FROM RATS OF DIFFERENT AGES: CHARACTERIZATION, IN VITRO EXPANSION AND ASSESSMENT OF NEURAL DIFFERENTIATION POTENTIAL
Decimo I., Bifari F., Bersan E., Malpeli G., Bonetti B., Pizzolo G., Krampera M., Chiamulera C., Fumagalli G. (Verona)
ON THE ROLE OF POLY(ADP-RIBOSE)POLYMERASE-1 IN A IN VIVO MODEL OF BRAIN ISCHEMIC PRECONDITIONING
Blasi F., Faraco G., Moroni F., Chiarugi A. (Firenze, Rende CS)
COMPARISON OF CIGUATOXINS AND BREVETOXINS POTENCY ON HUMAN VOLTAGE GATED SODIUM CHANNELS OF BRAIN AND PERIPHERAL SENSORY NEURONS EXPRESSED IN HUMAN EMBRYONIC KIDNEY CELLS
Dell'Ovo V., Bottein M., Tubaro A., Ramsdell J. (Trieste, Charleston)
CANNABINOID AND PPAR RECEPTORS: NOVEL TARGETS FOR THE TREATMENT OF LEVODOPA-INDUCED DYSKINESIAS
MORGESE M., TRABACE L., GIUFFRIDA A. (Foggia, San Antonio)
SOLUBLE ΒETA-AMYLOID1-42 INDUCES DEPRESSIVE-LIKE BEHAVIOUR IN RATS
Colaianna M., Tucci P., Cuomo V., Trabace L. (Foggia, Roma)
SPECIFIC NPY-Y1 RECEPTOR DELETION IN Y5R CONTAINING NEURONS IMPAIRS ANXIOUS BEHAVIOUR BUT NOT FEEDING BEHAVIOUR.
Longo A., Oberto A., Bertocchi I., Mele P., Palanza P., Sprengel R., Eva C. (Torino, Parma, Heidelberg)
EFFECTS OF SYSTEMIC ADMINISTRATION OF THE ESSENTIAL OIL OF BERGAMOT ON GROSS BEHAVIOUR AND EEG POWER SPECTRA RECORDED FROM THE HIPPOCAMPUS AND CEREBRAL CORTEX OF RAT
Rombola' L., Corasaniti M., Rotiroti D., Tassorelli C., Sakurada S., Bagetta G., Morrone L. (Rende CS, Catanzaro, Pavia, Sendai)
EFFECT OF LRRK2 PATHOLOGICAL MUTATION ON DOPAMINE METABOLISM IN PC12 CELLS
Spissy Y., Rocchitta G., Iaccarino C., Crosio C., Galiotto M., Desole M., Migheli R. (Sassari)
TRANSCRIPTIONAL SIGNATURES IN NEURODEGENERATIVE DISEASES
Diamanti D., Pollio G., Tarditi A., Remelli R., Terstappen G., Caricasole A. (Siena)
HIGH AFFINITY AND LOW AFFINITY N-METHYL-D-ASPARTATE AUTORECEPTORS FACILITATE RESPECTIVELY EXOCYTOSIS AND CARRIER-MEDIATED RELEASE OF GLUTAMATE IN RAT HIPPOCAMPUS.
Summa M., Musante V., Raiteri M., Pittaluga A. (Genova)